Checking in at 2026's midyear mark, LGM Pharma's Mike Stenberg revisits his 2025 predictions on inspections, onshoring, GLP-1 delivery, and AI adoption.
Mike Stenberg
Advertisement
Vice President – Business Development
LGM Pharma
Articles by Mike Stenberg
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Brent Wilhelm on Why Drug Shortages Persist Despite Available Inventory
2
Can Governance-by-Design Make AI Compliant in Pharma? (Part II)
3
FDA Activity Round Up – July 2026
4
Manufacturing Intelligence: Sizing Up Pharma's Biggest AI Deals, Part One
5